136 related articles for article (PubMed ID: 10074345)
21. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
Li J; Joo SH; Tsai MD
Biochemistry; 2003 Nov; 42(46):13476-83. PubMed ID: 14621993
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.
Brotherton DH; Dhanaraj V; Wick S; Brizuela L; Domaille PJ; Volyanik E; Xu X; Parisini E; Smith BO; Archer SJ; Serrano M; Brenner SL; Blundell TL; Laue ED
Nature; 1998 Sep; 395(6699):244-50. PubMed ID: 9751051
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor p16INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism.
Tevelev A; Byeon IJ; Selby T; Ericson K; Kim HJ; Kraynov V; Tsai MD
Biochemistry; 1996 Jul; 35(29):9475-87. PubMed ID: 8755727
[TBL] [Abstract][Full Text] [Related]
24. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
Li J; Melvin WS; Tsai MD; Muscarella P
Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
[TBL] [Abstract][Full Text] [Related]
25. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
[TBL] [Abstract][Full Text] [Related]
26. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
27. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
28. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
Zariwala M; Liu E; Xiong Y
Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
31. INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB.
Wolff B; Naumann M
Oncogene; 1999 Apr; 18(16):2663-6. PubMed ID: 10353611
[TBL] [Abstract][Full Text] [Related]
32. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
[TBL] [Abstract][Full Text] [Related]
33. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
Li J; Li H; Tsai MD
Biochemistry; 2003 Jun; 42(22):6921-8. PubMed ID: 12779347
[TBL] [Abstract][Full Text] [Related]
34. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data.
Yuan C; Selby TL; Li J; Byeon IJ; Tsai MD
Protein Sci; 2000 Jun; 9(6):1120-8. PubMed ID: 10892805
[TBL] [Abstract][Full Text] [Related]
36. A minimum folding unit in the ankyrin repeat protein p16(INK4).
Zhang B; Peng Zy
J Mol Biol; 2000 Jun; 299(4):1121-32. PubMed ID: 10843863
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
38. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
Suzuki T; Kitao S; Matsushime H; Yoshida M
EMBO J; 1996 Apr; 15(7):1607-14. PubMed ID: 8612584
[TBL] [Abstract][Full Text] [Related]
39. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]